Log in to save to my catalogue

Proteasome Inhibitors as Therapeutic Agents: Current and Future Strategies

Proteasome Inhibitors as Therapeutic Agents: Current and Future Strategies

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_inserm_00966293v1

Proteasome Inhibitors as Therapeutic Agents: Current and Future Strategies

About this item

Full title

Proteasome Inhibitors as Therapeutic Agents: Current and Future Strategies

Publisher

Schiphol: Bentham Science Publishers Ltd

Journal title

Current medicinal chemistry, 2003-03, Vol.10 (6), p.479-503

Language

English

Formats

Publication information

Publisher

Schiphol: Bentham Science Publishers Ltd

More information

Scope and Contents

Contents

In cells, protein degradation is a key pathway for the destruction of abnormal or damaged proteins as well as for the elimination of proteins whose presence is no longer required. Among the various cell proteases, the proteasome, a multicatalytic macromolecular complex, is specifically required for the degradation of ubiquitinated proteins. In norm...

Alternative Titles

Full title

Proteasome Inhibitors as Therapeutic Agents: Current and Future Strategies

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_inserm_00966293v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_inserm_00966293v1

Other Identifiers

ISSN

0929-8673

E-ISSN

1875-533X

DOI

10.2174/0929867033368231